CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Grant or award Director acquired 2,886 shares (grant or award)
- 4 Grant or award Director acquired 3,406 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Exercise or conversion President & CEO acquired 5,000 shares (option exercise)
- 4 Grant or award Director acquired 1,215 shares (grant or award)
- 4 Grant or award Director acquired 2,331 shares (grant or award)
- 4 Grant or award Director acquired 4,761 shares (grant or award)
- 4 Grant or award Director acquired 2,480 shares (grant or award)
- 4 Grant or award Director acquired 2,926 shares (grant or award)
- 4 Open-market buy President & CEO bought 582 shares at $4.81 ($2,799)
- 4 Open-market buy Chief Medical Officer bought 1,670 shares at $4.81 ($8,033)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 940 shares (grant or award)
- 4 Grant or award Director acquired 1,782 shares (grant or award)
- 4 Grant or award Director acquired 3,417 shares (grant or award)
- 4 Grant or award Director acquired 1,881 shares (grant or award)
Page 9 of 37 · 739 filings